Title |
Treatment and Management of Dementia Due to Alzheimer’s Disease
|
---|---|
Published in |
Current Treatment Options in Neurology, July 2015
|
DOI | 10.1007/s11940-015-0363-4 |
Pubmed ID | |
Authors |
Jennifer Rose V. Molano, Robin Bratt, Rhonna Shatz |
Abstract |
Alzheimer's disease (AD) is a progressive neurological disorder typically associated with episodic memory loss as the initial symptom, but individuals <65 years old may present with executive dysfunction, word finding difficulties, or visual processing deficits. In those with AD, curative treatments are not available, but there are interventions which may modify disease course, symptom appearance and severity, enhance quality of life for patient and caregivers, and maintain safety. Both pharmacological and non-pharmacological interventions are important. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 84 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 84 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 12 | 14% |
Student > Ph. D. Student | 10 | 12% |
Student > Bachelor | 9 | 11% |
Student > Master | 8 | 10% |
Other | 4 | 5% |
Other | 13 | 15% |
Unknown | 28 | 33% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 10 | 12% |
Psychology | 9 | 11% |
Neuroscience | 8 | 10% |
Nursing and Health Professions | 8 | 10% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 6% |
Other | 9 | 11% |
Unknown | 35 | 42% |
Attention Score in Context
This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 January 2016.
All research outputs
#3,198,000
of 22,816,807 outputs
Outputs from Current Treatment Options in Neurology
#74
of 471 outputs
Outputs of similar age
#42,917
of 262,949 outputs
Outputs of similar age from Current Treatment Options in Neurology
#4
of 10 outputs
Altmetric has tracked 22,816,807 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 471 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 262,949 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than 6 of them.